Skip to main content
. 2017 Aug 30;177(6):455–464. doi: 10.1530/EJE-17-0446

Figure 2.

Figure 2

Changes in glucose (A) and insulin (B) serum GLP-1 (C), GIP (D), glucagon (E), peptide YY (F), and OXM (G) following a MMT in patients with symptomatic PPH. Patients classified as either MMT Hypo (n = 7) or MMT Non-Hypo (n = 11), depending if their nadir glucose was <3 mmol/L. Data is shown as mean ± s.e.m. Statistically significant differences are shown as **P < 0.01, ***P < 0.0001.